Position in PTCT
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$92,981,643
+$19,706,223 QoQ
Shares Held
1,364,768
+41.5% QoQ
Ownership
1.65%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.8657647307088.ToString("F0")%
Shared 0.ToString("F0")%
None 0.1342352692911909.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Derivatives in PTCT
reported options exposure · as of Dec 31, 2020CallValue
$2,062,814
CallShares
33,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,307,109,707 across 562 Biotechnology names. PTCT ranks #20 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in PTCT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $92,981,643 | 1,364,768 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $73,275,420 | 964,658 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $27,752,066 | 452,209 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $28,275,917 | 578,950 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $64,701,209 | 1,269,647 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $48,347,241 | 1,071,051 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $6,124,132 | 165,071 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,182,150 | 136,761 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $6,558,631 | 225,460 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $7,957,894 | 288,748 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,744,954 | 77,865 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,743,714 | 92,051 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $3,721,256 | 76,822 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $4,155,490 | 108,868 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $1,544,201 | 30,761 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $2,315,147 | 57,792 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $5,296,862 | 141,969 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $5,164,834 | 129,672 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,337,606 | 62,822 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,931 | 93 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,561,223 | 32,972 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $2,062,814 | 33,800 | Call | Defined | 2021-02-11 | |
| 2020-12-31 | $23,435 | 384 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $13,744 | 294 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $256,896 | 5,063 | Shares | Defined | 2020-07-31 | |
| 2020-03-31 | $3,206,968 | 71,889 | Shares | Defined | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||